IMUX Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-02 | Vitt Daniel | director, officer: Chief Executive Officer | 300,000 | A-Award | A | 300,000 | 1.40 | 420,000.00 |
| 2023-01-02 | Whaley Glenn | officer: Chief Financial Officer | 110,000 | A-Award | A | 110,000 | 1.40 | 154,000.00 |
| 2023-01-02 | Nash Duane | director, officer: Executive Chairman | 132,000 | A-Award | A | 132,000 | 1.40 | 184,800.00 |
| 2023-01-02 | Muehler Andreas | officer: Chief Medical Officer | 132,000 | A-Award | A | 132,000 | 1.40 | 184,800.00 |
| 2022-12-14 | Neermann Joerg | director | 100,000 | P-Purchase | A | 47,000 | 1.26 | 59,032.00 |
| 2022-12-13 | Neermann Joerg | director | 53,000 | P-Purchase | A | 35,000 | 1.25 | 43,610.00 |
| 2022-11-23 | Neermann Joerg | director | 18,000 | P-Purchase | A | 18,000 | 1.39 | 25,020.00 |
| 2022-11-22 | Vitt Daniel | director, officer: President and CEO | 376,877 | P-Purchase | A | 8,000 | 1.35 | 10,799.20 |
| 2022-11-07 | Whaley Glenn | officer: Chief Financial Officer | 20,510 | P-Purchase | A | 5,000 | 1.50 | 7,475.00 |
| 2022-07-08 | Toernsen Monika Maria | director | 30,000 | A-Award | A | 30,000 | 4.30 | 129,000.00 |
| 2022-06-15 | Nash Duane | director, officer: Executive Chairman | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | Ossipow Vincent | director | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | PHILLIPS BARCLAY A | director | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | Muehler Andreas | officer: Chief Medical Officer | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | Neermann Joerg | director | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | van den Bossche Jan | director | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | HOWSON TAMAR D | director | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | Vitt Daniel | director, officer: President and CEO | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-15 | Whaley Glenn | officer: Chief Financial Officer | 10,000 | A-Award | A | 10,000 | 3.40 | 34,000.00 |
| 2022-06-03 | Whaley Glenn | officer: Chief Financial Officer | 12,568 | P-Purchase | A | 3,500 | 3.05 | 10,657.50 |
| 2022-06-03 | Vitt Daniel | director, officer: President and CEO | 368,877 | P-Purchase | A | 5,000 | 3.10 | 15,499.50 |
| 2022-05-12 | Muehler Andreas | officer: Chief Medical Officer | 297,986 | P-Purchase | A | 3,500 | 5.10 | 17,850.00 |
| 2022-05-12 | Nash Duane | director, officer: Executive Chairman | 16,032 | G-Gift | D | 6,000 | 0.00 | 0.00 |
| 2022-05-12 | Nash Duane | director, officer: Executive Chairman | 22,032 | P-Purchase | A | 10,000 | 5.03 | 50,300.00 |
| 2022-05-12 | Whaley Glenn | officer: Chief Financial Officer | 9,068 | P-Purchase | A | 3,000 | 5.08 | 15,240.00 |
| 2022-03-10 | Whaley Glenn | officer: PAO and PFO | 40,000 | A-Award | A | 40,000 | 10.88 | 435,200.00 |
| 2022-03-10 | Nash Duane | director, officer: Executive Chairman | 75,000 | A-Award | A | 75,000 | 10.88 | 816,000.00 |
| 2022-01-03 | Whaley Glenn | officer: PFO and PAO | 70,000 | A-Award | A | 70,000 | 10.73 | 751,100.00 |
| 2022-01-03 | Muehler Andreas | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 10.73 | 1,073,000.00 |
| 2022-01-03 | Vitt Daniel | director, officer: Chief Executive Officer | 215,000 | A-Award | A | 215,000 | 10.73 | 2,306,950.00 |
| 2021-11-08 | Nash Duane | director, officer: Executive Chairman | 12,032 | G-Gift | D | 3,000 | 0.00 | 0.00 |
| 2021-08-10 | Nash Duane | director, officer: Executive Chairman | 15,032 | P-Purchase | A | 1,000 | 9.80 | 9,800.00 |
| 2021-08-10 | Vitt Daniel | director, officer: Chief Executive Officer | 363,877 | P-Purchase | A | 1,000 | 9.60 | 9,600.00 |
| 2021-08-10 | Whaley Glenn | officer: PFO and PAO | 3,500 | P-Purchase | A | 1,500 | 9.85 | 14,775.00 |
| 2021-06-10 | Nash Duane | director, officer: Executive Chairman | 10,000 | A-Award | A | 10,000 | 14.77 | 147,700.00 |
| 2021-06-10 | HOWSON TAMAR D | director | 10,000 | A-Award | A | 10,000 | 14.77 | 147,700.00 |
| 2021-06-10 | PHILLIPS BARCLAY A | director | 10,000 | A-Award | A | 10,000 | 14.77 | 147,700.00 |
| 2021-06-10 | van den Bossche Jan | director | 10,000 | A-Award | A | 10,000 | 14.77 | 147,700.00 |
| 2021-06-10 | Neermann Joerg | director | 10,000 | A-Award | A | 10,000 | 14.77 | 147,700.00 |
| 2021-06-10 | Ossipow Vincent | director | 25,000 | A-Award | A | 25,000 | 14.77 | 369,250.00 |
| 2021-05-12 | Nash Duane | director, officer: Executive Chairman | 14,032 | P-Purchase | A | 4,000 | 12.75 | 51,000.00 |
| 2021-04-15 | Nash Duane | director, officer: Executive Chairman | 90,000 | A-Award | A | 90,000 | 15.44 | 1,389,600.00 |
| 2021-03-02 | Muehler Andreas | officer: Chief Medical Officer | 294,486 | P-Purchase | A | 10,006 | 15.54 | 155,493.24 |
| 2021-03-02 | Whaley Glenn | officer: PFO and PAO | 2,000 | P-Purchase | A | 1,000 | 16.48 | 16,480.00 |
| 2021-03-01 | Vitt Daniel | director, officer: Chief Executive Officer | 115,000 | A-Award | A | 115,000 | 15.72 | 1,807,800.00 |
| 2021-03-01 | Whaley Glenn | officer: PFO and PAO | 40,000 | A-Award | A | 40,000 | 15.72 | 628,800.00 |
| 2021-03-01 | Groeppel Manfred | officer: Chief Operating Officer | 45,000 | A-Award | A | 45,000 | 15.72 | 707,400.00 |
| 2020-10-22 | Nash Duane | director, officer: Executive Chairman | 120,000 | A-Award | A | 120,000 | 17.00 | 2,040,000.00 |
| 2020-08-10 | Whaley Glenn | officer: PFO and PAO | 1,000 | P-Purchase | A | 1,000 | 18.96 | 18,960.00 |
| 2020-07-21 | Vitt Daniel | director, officer: Chief Executive Officer | 362,877 | S-Sale | D | 1,300 | 15.62 | 20,309.77 |
| 2020-07-21 | Groeppel Manfred | officer: Chief Operating Officer | 278,830 | S-Sale | D | 650 | 15.62 | 10,154.89 |
| 2020-07-20 | Vitt Daniel | director, officer: Chief Executive Officer | 364,177 | S-Sale | D | 5,000 | 14.44 | 72,200.50 |
| 2020-07-20 | Groeppel Manfred | officer: Chief Operating Officer | 279,480 | S-Sale | D | 5,000 | 14.44 | 72,200.50 |
| 2020-07-02 | Vitt Daniel | director, officer: Chief Executive Officer | 80,000 | A-Award | A | 80,000 | 12.30 | 984,000.00 |
| 2020-07-02 | Groeppel Manfred | officer: Chief Operating Officer | 30,000 | A-Award | A | 30,000 | 12.30 | 369,000.00 |
| 2020-07-02 | Whaley Glenn | officer: PFO and PAO | 30,000 | A-Award | A | 30,000 | 12.30 | 369,000.00 |
| 2020-07-02 | van den Bossche Jan | director | 15,000 | A-Award | A | 15,000 | 12.30 | 184,500.00 |
| 2020-07-02 | Neermann Joerg | director | 15,000 | A-Award | A | 15,000 | 12.30 | 184,500.00 |
| 2020-07-02 | PHILLIPS BARCLAY A | director | 15,000 | A-Award | A | 15,000 | 12.30 | 184,500.00 |
| 2020-07-02 | Nash Duane | director, officer: Executive Chairman | 45,000 | A-Award | A | 45,000 | 12.30 | 553,500.00 |
| 2020-07-02 | HOWSON TAMAR D | director | 15,000 | A-Award | A | 15,000 | 12.30 | 184,500.00 |
| 2020-04-29 | Whaley Glenn | officer: PFO and PAO | 15,000 | A-Award | A | 15,000 | 8.84 | 132,600.00 |
| 2019-12-04 | Nash Duane | director, officer: Executive Chairman | 10,032 | S-Sale | D | 4,400 | 6.96 | 30,624.00 |
| 2019-12-03 | Nash Duane | director, officer: Executive Chairman | 14,432 | F-InKind | D | 7,930 | 7.15 | 56,732.01 |
| 2019-12-02 | Nash Duane | director, officer: Executive Chairman | 864,159 | M-Exempt | D | 22,157 | 0.00 | 0.00 |
| 2019-12-02 | Nash Duane | director, officer: Executive Chairman | 22,362 | M-Exempt | A | 22,157 | 0.00 | 0.00 |
| 2019-12-01 | Whaley Glenn | officer: PFO and PAO | 15,000 | A-Award | A | 15,000 | 7.37 | 110,550.00 |
| 2019-11-18 | PHILLIPS BARCLAY A | director | 29,959 | A-Award | A | 29,959 | 7.63 | 228,587.17 |
| 2019-10-11 | HOWSON TAMAR D | director | 29,959 | A-Award | A | 29,959 | 9.54 | 285,808.86 |
| 2019-08-01 | Groeppel Manfred | officer: Chief Operating Officer | 20,000 | A-Award | A | 20,000 | 13.29 | 265,800.00 |
| 2019-08-01 | Vitt Daniel | director, officer: Chief Executive Officer | 65,000 | A-Award | A | 65,000 | 13.29 | 863,850.00 |
| 2019-07-22 | van den Bossche Jan | director | 29,959 | A-Award | A | 29,959 | 13.63 | 408,341.17 |
| 2019-07-22 | Nash Duane | director, officer: Executive Chairman | 29,959 | A-Award | A | 29,959 | 13.63 | 408,341.17 |
| 2019-07-22 | Neermann Joerg | director | 29,959 | A-Award | A | 29,959 | 13.63 | 408,341.17 |
| 2019-07-22 | Ossipow Vincent | director | 29,959 | A-Award | A | 29,959 | 13.63 | 408,341.17 |
| 2019-07-22 | Patel Sanjay S | officer: Chief Financial Officer | 79,891 | A-Award | A | 79,891 | 13.63 | 1,088,914.33 |
| 2019-01-11 | Cox Russell J. | director, officer: Chief Executive Officer | 1,854,376 | A-Award | A | 1,854,376 | 0.00 | 0.00 |
| 2019-01-11 | Cox Russell J. | director, officer: Chief Executive Officer | 0 | D-Return | D | 1,588,832 | 6.30 | 10,009,641.60 |
| 2019-01-11 | Nash Duane | director, officer: Executive Chairman | 0 | D-Return | D | 93,377 | 0.43 | 40,002.71 |
| 2019-01-11 | Nash Duane | director, officer: Executive Chairman | 886,316 | A-Award | A | 886,316 | 0.00 | 0.00 |
| 2019-01-11 | Swanson Michael V. | officer: Chief Financial Officer, EVP | 817,826 | A-Award | A | 817,826 | 0.00 | 0.00 |
| 2019-01-11 | Ashley Robert A. | officer: Chief Scientific Officer, EVP | 0 | D-Return | D | 93,377 | 0.43 | 40,002.71 |
| 2019-01-11 | Ashley Robert A. | officer: Chief Scientific Officer, EVP | 816,634 | A-Award | A | 816,634 | 0.00 | 0.00 |
| 2019-01-11 | Swanson Michael V. | officer: Chief Financial Officer, EVP | 0 | D-Return | D | 90,000 | 8.00 | 720,000.00 |
| 2019-01-11 | DUNN JOHN MICHAEL | officer: General Counsel and Secretary | 0 | D-Return | D | 50,000 | 19.03 | 951,500.00 |
| 2019-01-11 | DUNN JOHN MICHAEL | officer: General Counsel and Secretary | 724,848 | A-Award | A | 724,848 | 0.00 | 0.00 |
| 2018-09-25 | Halperin Errol R. | director | 0 | S-Sale | D | 89,417 | 0.29 | 25,939.87 |
| 2018-09-24 | BIENAIME JEAN JACQUES | director | 18,500 | S-Sale | D | 26,619 | 0.30 | 8,001.67 |
| 2018-09-19 | Godshall Douglas Evan | director | 0 | S-Sale | D | 69,375 | 0.35 | 24,191.06 |
| 2018-09-17 | Satter Muneer A | director, 10 percent owner | 0 | S-Sale | D | 7,044,777 | 0.29 | 2,054,256.97 |
| 2018-09-14 | Satter Muneer A | director, 10 percent owner | 7,044,777 | S-Sale | D | 447,500 | 0.36 | 160,384.00 |
| 2018-09-13 | Hasnain Faheem | director | 4,500 | S-Sale | D | 118,243 | 0.44 | 51,766.79 |
| 2018-09-13 | Hasnain Faheem | director | 122,743 | S-Sale | D | 59,200 | 0.44 | 25,911.84 |
| 2018-09-13 | Satter Muneer A | director, 10 percent owner | 7,492,277 | S-Sale | D | 3,890,000 | 0.50 | 1,930,996.00 |
| 2018-09-13 | BIENAIME JEAN JACQUES | director | 45,119 | S-Sale | D | 20,000 | 0.47 | 9,400.00 |
| 2018-09-12 | Cohen Cheryl | director | 0 | S-Sale | D | 3,500 | 0.55 | 1,925.00 |
| 2018-07-01 | Stern Aron | officer: Chief Administrative Officer | 20,000 | A-Award | A | 20,000 | 6.85 | 137,000.00 |
| 2018-06-09 | Swanson Michael V. | officer: Chief Financial Officer, EVP | 75,000 | A-Award | A | 75,000 | 5.00 | 375,000.00 |
| 2018-06-09 | MURAWSKI RICHARD M | officer: Vice President, Manufacturing | 45,000 | A-Award | A | 45,000 | 5.00 | 225,000.00 |
| 2018-06-09 | Henry Andrew | officer: VP, Clinical Operations | 50,000 | A-Award | A | 50,000 | 5.00 | 250,000.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.